Brian Thomas
Psychiatry · Atlanta, GANPI 1649309329
Payments from drug & device makers
Across 731 payments — averaging $20.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$3K
- Tris Pharma Inc$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$1K
- AbbVie$1K
- Lundbeck LLC$926
- plus $7K from 26 others
What the payments were for
- Speaking & faculty fees$5003%
- Food & beverage$14,44096%
- Education$811%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 98 | $2,883 |
| Tris Pharma Inc | 65 | $1,185 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 53 | $1,170 |
| Otsuka America Pharmaceutical, Inc. | 58 | $1,012 |
| AbbVie(2 entities) | 52 | $1,000 |
| Lundbeck LLC | 53 | $926 |
| Corium, LLC | 41 | $780 |
| Johnson & Johnson | 39 | $767 |
| Axsome Therapeutics, Inc. | 25 | $674 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $669 |
| Ironshore Pharmaceuticals Inc. | 29 | $634 |
| Bausch Health US, LLC | 27 | $518 |
| Neurocrine Biosciences, Inc. | 24 | $392 |
| Alfasigma USA, Inc. | 20 | $315 |
| Noven Therapeutics, LLC | 14 | $307 |
| Teva Pharmaceuticals USA, Inc. | 18 | $284 |
| Neos Therapeutics, LP | 15 | $256 |
| Vanda Pharmaceuticals Inc. | 11 | $238 |
| Collegium Pharmaceutical, Inc. | 10 | $193 |
| Idorsia Pharmaceuticals US Inc | 10 | $183 |
| Shire North American Group Inc | 6 | $120 |
| Adlon Therapeutics L.p. | 7 | $115 |
| Merck | 6 | $96 |
| Eisai Inc. | 4 | $61 |
| Brainsway USA Inc | 2 | $49 |
| Jazz Pharmaceuticals Inc. | 2 | $45 |
| Noven Pharmaceuticals, Inc. | 2 | $37 |
| Arbor Pharmaceuticals, Inc. | 2 | $31 |
| Alkermes, Inc. | 1 | $25 |
| Tempus AI, Inc | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$292
How this compares
$15,021 in reported general payments places this provider in the 90th percentile of 900 psychiatry providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyvanseLisdexamfetamine Dimesylate | 18 | $10,960 |
| BelsomraSuvorexant | 11 | $2,765 |
| Bupropion XlBupropion Hcl | 13 | $543 |
| Paroxetine Hcl | 24 | $285 |
| Lamotrigine | 15 | $262 |
| Clonazepam | 28 | $243 |
| Trazodone Hcl | 20 | $159 |
| Alprazolam | 12 | $68 |
| Lorazepam | 12 | $66 |
| Fluoxetine Hcl | 15 | $3 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $669 | $10,96018 claims |
| MerckBelsomra | $96 | $2,76511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 900 psychiatry providers in Georgia.
Other psychiatry in Atlanta
- Robert RiesenbergAtlanta$51.1M
- Saundra Maass-RobinsonAtlanta$11.1M
- David PurselleAtlanta$7.4M
- Bethany DavisAtlanta$4.4M
- Patricio Riva PosseAtlanta$884K
- Kerry ResslerAtlanta$365K
- Boadie DunlopAtlanta$345K
- Michael BurkeAtlanta$328K
- Bryon EvansAtlanta$211K
- Nurul HoqueAtlanta$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.